ORIC icon

Oric Pharmaceuticals
ORIC

Overview Fund Activity

64 hedge funds and large institutions have $192M invested in Oric Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 18 closing their positions.

Holders
64
Holders Change
-12
Holders Change %
-15.79%
% of All Funds
1.03%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
6
Increased
21
Reduced
20
Closed
18
Calls
$1.04M
Puts
$190K
Net Calls
+$850K
Net Calls Change
+$431K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$11.1M
2
Alkeon Capital Management
2
Alkeon Capital Management
New York
$14.1M
3
PM
3
Prosight Management
Texas
$6.95M
4
MAM
4
Monaco Asset Management
Monaco
$3.28M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$9.11M

Top Sellers

1
O
1
OrbiMed
New York
$9.47M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$23.7M
3
BlackRock
3
BlackRock
New York
$4.7M
4
UOC
4
UBS O'Connor
Illinois
$0
5
DCM
5
DAFNA Capital Management
California
$1.56M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$23.7M 4,016,608 -331,784 -8%
CG
2
Column Group
California
$21M 3,568,181 – –
EC
3
EcoR1 Capital
California
$20.1M 3,418,068 – –
Alkeon Capital Management
4
Alkeon Capital Management
New York
$14.1M 2,399,252 +292,284 +14%
SCM
5
Suvretta Capital Management
New York
$11.2M 1,902,643 – –
Millennium Management
6
Millennium Management
New York
$11.1M 1,883,978 +355,370 +23%
O
7
OrbiMed
New York
$9.47M 1,607,568 -480,000 -23%
Vanguard Group
8
Vanguard Group
Pennsylvania
$9.11M 1,546,285 +199,423 +15%
BC
9
Boxer Capital
California
$7.36M 1,054,000 – –
SCM
10
Silverarc Capital Management
Massachusetts
$7.28M 1,236,296 +27,304 +2%
PM
11
Prosight Management
Texas
$6.95M 1,180,000 +243,666 +26%
IFA
12
Invus Financial Advisors
New York
$5.93M 1,007,575 – –
BlackRock
13
BlackRock
New York
$4.7M 798,388 -240,554 -23%
EC
14
Euclidean Capital
New York
$4.4M 747,550 – –
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$3.55M 602,787 +68,899 +13%
MSKCC
16
Memorial Sloan Kettering Cancer Center
New York
$3.55M 602,272 – –
MAM
17
Monaco Asset Management
Monaco
$3.28M 557,430 +216,248 +63%
ACH
18
ArrowMark Colorado Holdings
Colorado
$3.08M 523,158 -20,654 -4%
AG
19
Artal Group
Luxembourg
$2.36M 400,000 – –
Renaissance Technologies
20
Renaissance Technologies
New York
$1.87M 316,800 -84,600 -21%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$1.67M 283,711 -597 -0.2%
OMC
22
Oasis Management Company
Cayman Islands
$1.6M 272,480 – –
DCM
23
DAFNA Capital Management
California
$1.56M 264,237 -149,289 -36%
GCP
24
GSA Capital Partners
United Kingdom
$1.4M 238,359 +12,759 +6%
EI
25
EAM Investors
California
$1.12M 190,455 +190,455 New
1
2 3 4